<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03252132</url>
  </required_header>
  <id_info>
    <org_study_id>IDNC-DD2-MUSCLE</org_study_id>
    <nct_id>NCT03252132</nct_id>
  </id_info>
  <brief_title>Resistance Training in Patients With Diabetic Neuropathy</brief_title>
  <official_title>Resistance Training in Patients With Diabetic Neuropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Pain Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danish Pain Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a population-based study of type 2 diabetes patients with and without neuropathy&#xD;
      recruited from the Danish National Type 2 Diabetes cohort (DD2).&#xD;
&#xD;
      Diabetic patients with neuropathy may suffer from incapacitating symptoms such as pain,&#xD;
      muscle weakness and impaired balance. Muscle weakness may cause reduced balance and postural&#xD;
      instability increasing the risk of frequent falls and thereby increased morbidity and&#xD;
      mortality. Thus, diabetic neuropathy is associated with significant disabilities having major&#xD;
      impact on activities of daily living and quality of life.&#xD;
&#xD;
      The effects of resistance training on neuropathy symptoms, muscle strength and muscle&#xD;
      structure in patients with and with diabetic neuropathy will be examined.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Perspective: The studies will likely improve the understanding of diabetic neuropathy and the&#xD;
      relation between risk of falls in patients with and without motor dysfunction. The results&#xD;
      may enable new and more precise recommendations for exercise in diabetic patients with&#xD;
      diabetic neuropathy. In addition, the results may lead to a better understanding of the&#xD;
      mechanisms underlying the effects of training. The improvement of motor function may lead to&#xD;
      improved gait stability, fewer fall injuries and better quality of life for type 2 diabetes&#xD;
      patients, resulting in lower morbidity and mortality.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 10, 2017</start_date>
  <completion_date type="Actual">March 31, 2019</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>International, randomized controlled training trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraepidermal nerve fiber density (IENFD)</measure>
    <time_frame>Change from baseline IENFD at 12 weeks</time_frame>
    <description>1-2 small biopsies of 3 mm will be performed before and after the 12-week training period to evaluate small nerve fiber function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle strength (isokinetic strength)</measure>
    <time_frame>Change from baseline IENFD at 12 weeks</time_frame>
    <description>Isokinetic dynamometry will be used to determine the maximal isokinetic strength of the flexors and extensors at the knee, hip and ankle.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">109</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Polyneuropathy Diabetes</condition>
  <condition>Diabetes Complications</condition>
  <condition>Diabetic Peripheral Neuropathy</condition>
  <condition>Muscle Weakness</condition>
  <condition>Fall Patients</condition>
  <arm_group>
    <arm_group_label>12-week resistance training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No training</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>12-week resistance training</intervention_name>
    <description>Training will consist of a minimum of 5 supervised training sessions every 2 weeks and each session will be approximately 60 minutes in duration. Patients will be performing resistance training consisting of at least 3 exercises affecting the largest muscle groups of the body, training the most basic movement patterns that work the entire body as a coordinated system. Patients will train according to a linear progressive model with a slow increase in weight every training session focusing on the flexors, extensors of the ankle and knee and on flexors, extensors and abductors of the hip.</description>
    <arm_group_label>12-week resistance training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of type 2 diabetes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neuropathy due to any other cause&#xD;
&#xD;
               -  BMI &gt;40&#xD;
&#xD;
               -  Pacemaker&#xD;
&#xD;
               -  Comorbidity that contraindicates exercise&#xD;
&#xD;
               -  History of stroke with affection of the lower extremities&#xD;
&#xD;
               -  Ischemic heart disease&#xD;
&#xD;
               -  Any other neurological disease&#xD;
&#xD;
               -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karolina Snopek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Danish Pain Research Center, Aarhus University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Danish Pain Research Center, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 10, 2017</study_first_submitted>
  <study_first_submitted_qc>August 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2017</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
    <mesh_term>Polyneuropathies</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

